Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha]
Acasti Pharma, Inc. - Class A (ACST)
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
acastipharma.com/investors
Company Research
Source: Seeking Alpha
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q2 2020 Results - Earnings Call Transcript Start Time: 13:00 January 1, 0000 1:40 PM ET Acasti Pharma Inc. (NASDAQ: ACST Q2 2020 Conference Call November 13, 2019, 13:00 PM ET Company Participants Jan D’Alvise - President and CEO Jean-François Boily - VP, Finance Pierre Lemieux - Co-Founder, COO and CSO Brian Groch - CCO David Waldman - Crescendo Communications Conference Call Participants Nathan Weinstein - Aegis Capital Leland Gershell - Oppenheimer Robert Hazlett - BTIG Richard Ehrlich - JH Darbie Operator Good day, ladies and gentlemen, and welcome to the Acasti Pharma Second Quarter 2020 Business Update Conference Call. After the presentation, there will be a question-and-answer session. [Operator Instructions]. At this time, it’s my pleasure to turn the floor over to Mr. David Waldman, Investor Relations. Sir, the floor is yours. Thank You. Good afternoon, everyone, and welcome to Acasti Pharma's second quarter fiscal 2020 confere
Show less
Read more
Impact Snapshot
Event Time:
ACST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACST alerts
High impacting Acasti Pharma, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
ACST
News
- Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business HighlightsGlobeNewswire
- Acasti Pharma Inc. (NASDAQ: ACST) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $6.00 price target on the stock.MarketBeat
- Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial [Yahoo! Finance]Yahoo! Finance
- Acasti Announces Poster Detailing its GTX-104 STRIVE-ON TrialGlobeNewswire
ACST
Earnings
- 2/12/24 - Beat
ACST
Sec Filings
- 2/13/24 - Form SC
- 2/12/24 - Form 8-K
- 2/12/24 - Form 10-Q
- ACST's page on the SEC website